When will ADHD medication shortage end?

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

ChudsMgee

Membership Revoked
Removed
Joined
Jan 7, 2023
Messages
54
Reaction score
24
This is getting a little ridiculous. I am having to change meds around all day, resending to other pharmacies etc

Now its no guarantee for Vyvanse, Concerta, etc to be in stock either

Members don't see this ad.
 
This is getting a little ridiculous. I am having to change meds around all day, resending to other pharmacies etc

Now its no guarantee for Vyvanse, Concerta, etc to be in stock either

So it turns out a significant portion of the shortage is driven by provisions of a settlement that the US government reached with a trio of pharmaceutical distributors in 2021. This settlement contained provisions that would require them to limit the quantity of controlled substances a given pharmacy was allowed to order in a given month and to refuse to provide more than these limits. The specific details of these limits are not public knowledge and are not disclosed to individual pharmacies. This is a big part of why there has been tremendous variability between individual stores in the same chain as to whether they can fill a stimulant script - it's basically a function of how many stimulant scripts have been filled there this month, and the stores who have filled "too many" simply can't fill more until their quota resets.

I wish I was making this up.
 
Last edited:
  • Like
  • Wow
  • Hmm
Reactions: 17 users
So it turns out a significant portion of the shortage is driven by provisions of a settlement that the US government reached with a trio of pharmaceutical manufacturers in 2021. This settlement contained provisions that would require them to limit the quantity of controlled substances a given pharmacy was allowed to order in a given month and to refuse to provide more than these limits. The specific details of these limits are not public knowledge and are not disclosed to individual pharmacies. This is a big part of why there has been tremendous variability between individual stores in the same chain as to whether they can fill a stimulant script - it's basically a function of how many stimulant scripts have been filled there this month, and the stores who have filled "too many" simply can't fill more until their quota resets.

I wish I was making this up.
Does anyone know the total number of scripts once the online pill mills started versus the number produced (I know there were supply chain disruptions with the production) versus the change related to that settlement? I would love to see some sources or data, particularly on the increase in psychostim Rxes.
 
Members don't see this ad :)
So it turns out a significant portion of the shortage is driven by provisions of a settlement that the US government reached with a trio of pharmaceutical manufacturers in 2021. This settlement contained provisions that would require them to limit the quantity of controlled substances a given pharmacy was allowed to order in a given month and to refuse to provide more than these limits. The specific details of these limits are not public knowledge and are not disclosed to individual pharmacies. This is a big part of why there has been tremendous variability between individual stores in the same chain as to whether they can fill a stimulant script - it's basically a function of how many stimulant scripts have been filled there this month, and the stores who have filled "too many" simply can't fill more until their quota resets.

I wish I was making this up.
Do you have any articles about what exactly is taking place legally and the rationale behind it? I'd love to read more. But also want to reference other providers in this office (especially those who do not prescribe) about what is going on in this country with the term of ADHD and role of stimulants good and bad. I don't think those who are not involved in prescribing are aware of what diagnosing ADHD fully means and that it is not a panacea. Medication management, especially controlled substances is complex. And we are dealing now with these new logistical factors. So before we get people's hopes up that "it was all ADHD and let's look at med options," let's be careful about how we deliver our care and what we can find that will longitudinally be helpful.
 
Do you have any articles about what exactly is taking place legally and the rationale behind it? I'd love to read more. But also want to reference other providers in this office (especially those who do not prescribe) about what is going on in this country with the term of ADHD and role of stimulants good and bad. I don't think those who are not involved in prescribing are aware of what diagnosing ADHD fully means and that it is not a panacea. Medication management, especially controlled substances is complex. And we are dealing now with these new logistical factors. So before we get people's hopes up that "it was all ADHD and let's look at med options," let's be careful about how we deliver our care and what we can find that will longitudinally be helpful.


 
  • Like
  • Wow
Reactions: 6 users
"In recent years, ADHD medication prescriptions have risen more than the drug companies or government agencies predicted. According to the health data company Trilliant Health, Adderall prescriptions for adults rose 15.1% during 2020, double the 7.4% rise seen the year before." And in 2021, it further increased if I recall. Prescriptions have also dramatically increased is my understanding. So limited supply as mentioned,and huge increases in demand.

But yeah it sucks because its affecting everything and pharmacies wont disclose to patients what they have in stock so its really freaking hard sometimes. Especially if pt has crap insurance.
 
  • Like
Reactions: 2 users
So it turns out a significant portion of the shortage is driven by provisions of a settlement that the US government reached with a trio of pharmaceutical distributors in 2021. This settlement contained provisions that would require them to limit the quantity of controlled substances a given pharmacy was allowed to order in a given month and to refuse to provide more than these limits. The specific details of these limits are not public knowledge and are not disclosed to individual pharmacies. This is a big part of why there has been tremendous variability between individual stores in the same chain as to whether they can fill a stimulant script - it's basically a function of how many stimulant scripts have been filled there this month, and the stores who have filled "too many" simply can't fill more until their quota resets.

I wish I was making this up.
Another front in 'The War on Drugs,' I suppose...soon to be followed by 'The War on Supply Chain Disruptions,' I'm sure.
 
  • Like
Reactions: 1 user

Much appreciated the info until I fell into the horrifying rabbit hole of John Q Public’s’ comments.
 
  • Like
Reactions: 1 users
"In recent years, ADHD medication prescriptions have risen more than the drug companies or government agencies predicted. According to the health data company Trilliant Health, Adderall prescriptions for adults rose 15.1% during 2020, double the 7.4% rise seen the year before." And in 2021, it further increased if I recall. Prescriptions have also dramatically increased is my understanding. So limited supply as mentioned,and huge increases in demand.

But yeah it sucks because its affecting everything and pharmacies wont disclose to patients what they have in stock so its really freaking hard sometimes. Especially if pt has crap insurance.
Glad you had that info but I would expect a real ramp up to be more in the 2021 and 2022 years as it took some time for the NP/venture cap pill mills to come online with the suspension of Ryan Haight for COVID.
 
  • Like
Reactions: 1 users
I know some will disagree, which I respect. But it feels more like an over use and over demand issue that is now feeling the burn of warranted regulations to minimize another prescription epidemic. I have treated legit adhd and highly enjoy working with patients. But this hot mess is unfair to them and before things are back in a better line, it likely needs to get worse.
 
  • Like
Reactions: 4 users
Glad you had that info but I would expect a real ramp up to be more in the 2021 and 2022 years as it took some time for the NP/venture cap pill mills to come online with the suspension of Ryan Haight for COVID.

Not necessarily. Cerebral, who was one of the biggest players there before the investigation, was well online in early 2020 and did a ton of "ADHD" advertising over the course of 2020. Done.com was around the same timeline. A lot of these telehealth platforms existed before COVID lockdowns but accelerated immensely as soon as they saw the dollar signs with controlled meds, so it wouldn't surprise me if they rocketed off over the course of 2020.
 
  • Like
Reactions: 1 users
Members don't see this ad :)
I blame TikTok with all the self-diagnosing and ADHD adds lol
 
  • Like
  • Haha
Reactions: 8 users
Generic Concerta is essentially discontinued so that’s not really a shortage.
Better off with Focalin XR + Focalin IR PRN qafter school for most kids anyway. If we had a real OROS system with generic Concerta it would be a different story. Stimulants with sustained releases that do not create spikes are just inferior for most patients. I think it can hard for some patients and even doctors to understand this concept as we are so trained to want stable blood levels and low max levels with most of our medications.
 
  • Like
  • Hmm
Reactions: 3 users
OK everyone, you do know that "adult onset ADHD" is mostly questionable at best. You are using our relatively proud industry into the depths of embarrassment and validating the criticism of our craft. ADHD does not evaporate with patients who happen to turn 18, none the less, it doesn't become epidemic among college student who think they need stimulants' to perform at university. Adult onset "ADHD" is highly suspect until proven otherwise. The use of stimulants that are "prescribed and therefore OK" is a slippery slope. We don't want to be drug pushers. If this is part of your business plan, please review your ethics.
 
  • Like
Reactions: 8 users
OK everyone, you do know that "adult onset ADHD" is mostly questionable at best. You are using our relatively proud industry into the depths of embarrassment and validating the criticism of our craft. ADHD does not evaporate with patients who happen to turn 18, none the less, it doesn't become epidemic among college student who think they need stimulants' to perform at university. Adult onset "ADHD" is highly suspect until proven otherwise. The use of stimulants that are "prescribed and therefore OK" is a slippery slope. We don't want to be drug pushers. If this is part of your business plan, please review your ethics.
I don't think a single person in this entire thread (or on this forum) was saying anything in disagreement with what you said about adult onset ADHD. The majority of the discussion has been about ensuring some stability for our patients who are suffering due to this shortage and attempts to come up with solutions. Your comment here seems a bit out of place.
 
  • Like
Reactions: 5 users

The 2022 aggregate production quotas of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate, dexmethylphenidate, lisdexmethylphenidate , and methylphenidate were NOT increased for 2023. DEA said the manufacturers reported the 2022 supply was enough for domestic and export purposes. But that does not factor increases in export activities from 2022-2023.

"
Issue: DEA received comments from five DEA-registered manufacturers regarding 10 different schedule I and II controlled substances, requesting that the proposed APQ for d-amphetamine (for conversion), dexmethylphenidate (for conversion), dexmethylphenidate (for sale), isomethadone, lisdexamfetamine, methylphenidate (for conversion), methylphenidate (for sale), noroxymorphone (for conversion), oripavine, and oxymorphone (for conversion) be established at sufficient levels to allow for manufacturers to meet medical and scientific needs.


DEA Response: DEA considered the comments for these specific controlled substances and determined that an increase from DEA's proposed APQs are not necessary at this time, as reflected below in the section titled Determination of 2023 Aggregate Production Quotas and Assessment of Annual Needs"


My math says there is going to be 15+% shortage for all of 2023, which might get worse in 2024.
 
Last edited:
  • Like
Reactions: 1 user

The 2022 aggregate production quotas of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate, dexmethylphenidate, lisdexmethylphenidate , and methylphenidate were NOT increased for 2023. DEA said the manufacturers reported the 2022 supply was enough for domestic and export purposes. But that does not factor increases in export activities from 2022-2023.

"
Issue: DEA received comments from five DEA-registered manufacturers regarding 10 different schedule I and II controlled substances, requesting that the proposed APQ for d-amphetamine (for conversion), dexmethylphenidate (for conversion), dexmethylphenidate (for sale), isomethadone, lisdexamfetamine, methylphenidate (for conversion), methylphenidate (for sale), noroxymorphone (for conversion), oripavine, and oxymorphone (for conversion) be established at sufficient levels to allow for manufacturers to meet medical and scientific needs.


DEA Response: DEA considered the comments for these specific controlled substances and determined that an increase from DEA's proposed APQs are not necessary at this time, as reflected below in the section titled Determination of 2023 Aggregate Production Quotas and Assessment of Annual Needs"


My math says there is going to be 15+% shortage for all of 2023, which might get worse in 2024.

FML
 
  • Like
  • Sad
Reactions: 2 users
Glad you had that info but I would expect a real ramp up to be more in the 2021 and 2022 years as it took some time for the NP/venture cap pill mills to come online with the suspension of Ryan Haight for COVID.
They were real quick starting up.
 
Better off with Focalin XR + Focalin IR PRN qafter school for most kids anyway. If we had a real OROS system with generic Concerta it would be a different story. Stimulants with sustained releases that do not create spikes are just inferior for most patients. I think it can hard for some patients and even doctors to understand this concept as we are so trained to want stable blood levels and low max levels with most of our medications.
My admittedly limited knowledge speaking as a family doctor, I thought concert is outer layer was immediate release methylphenidate and the inner part was the more sustained release part.
 
My admittedly limited knowledge speaking as a family doctor, I thought concert is outer layer was immediate release methylphenidate and the inner part was the more sustained release part.
Concerta branded is an immediate release (just under 1/3 of the mg listed) followed by an osmotic pump that releases two seperate times. It is effectively taking Ritalin immediately, then Ritalin again 3-4 hours later then again 3-4 later. The magic in the technology is that it provides the spike in stimulant level on 3 occasions with only needing to take the one pill which is great for convenience and adherence.

Also, don't ever feel bad about not knowing as much about something as a sub-specialist. If any child/adolescent psychiatrist didn't know more than you about psychostimulants it would be a problem. You know more about 95% of medicine than I do.
 
  • Like
Reactions: 4 users
Concerta branded is an immediate release (just under 1/3 of the mg listed) followed by an osmotic pump that releases two seperate times. It is effectively taking Ritalin immediately, then Ritalin again 3-4 hours later then again 3-4 later. The magic in the technology is that it provides the spike in stimulant level on 3 occasions with only needing to take the one pill which is great for convenience and adherence.

Also, don't ever feel bad about not knowing as much about something as a sub-specialist. If any child/adolescent psychiatrist didn't know more than you about psychostimulants it would be a problem. You know more about 95% of medicine than I do.
TBH I hadn't heard anyone talk about the spikiness being preferable in this way before. Is there a theorized mechanism for that benefit? Patient's "notice" that they took it several times? Ramp in DA action is more important than tonic action? Probably the one class of meds that many adult psych residencies do not teach in sufficient detail.
 
  • Like
Reactions: 1 user
TBH I hadn't heard anyone talk about the spikiness being preferable in this way before. Is there a theorized mechanism for that benefit? Patient's "notice" that they took it several times? Ramp in DA action is more important than tonic action? Probably the one class of meds that many adult psych residencies do not teach in sufficient detail.
Yes I don't have the research in front of me now but my attending in fellowship sat in a lot of the FDA approvals for psychostimulants. We were trained to basically never using long acting Ritalin (Metadate CD is better but has a wonky release where less is IR and more releases later), Focalin XR and Adderall XR are perfectly biphasic release (1/2 IR, 1/2 released 3.5-4 hours later). Concerta is the only triphasic. I generally do not like Vyvanse because of it's gradual release. This is also a concern with the new QHS stimulant.
 
  • Like
Reactions: 2 users
Yes I don't have the research in front of me now but my attending in fellowship sat in a lot of the FDA approvals for psychostimulants. We were trained to basically never using long acting Ritalin (Metadate CD is better but has a wonky release where less is IR and more releases later), Focalin XR and Adderall XR are perfectly biphasic release (1/2 IR, 1/2 released 3.5-4 hours later). Concerta is the only triphasic. I generally do not like Vyvanse because of it's gradual release. This is also a concern with the new QHS stimulant.

By “long acting Ritalin” I think it’s important to differentiate between Ritalin SR and Ritalin LA. Ritalin SR is the lower efficacy wax matrix tablet. Ritalin LA is also a biphasic release bead system.
 
  • Like
Reactions: 1 user
Concerta branded is an immediate release (just under 1/3 of the mg listed) followed by an osmotic pump that releases two seperate times. It is effectively taking Ritalin immediately, then Ritalin again 3-4 hours later then again 3-4 later. The magic in the technology is that it provides the spike in stimulant level on 3 occasions with only needing to take the one pill which is great for convenience and adherence.

Also, don't ever feel bad about not knowing as much about something as a sub-specialist. If any child/adolescent psychiatrist didn't know more than you about psychostimulants it would be a problem. You know more about 95% of medicine than I do.
It was self-effacing humor, trust me I have plenty of confidence in my medical knowledge (probably more than is justified if I'm being honest).
 
Yes I don't have the research in front of me now but my attending in fellowship sat in a lot of the FDA approvals for psychostimulants. We were trained to basically never using long acting Ritalin (Metadate CD is better but has a wonky release where less is IR and more releases later), Focalin XR and Adderall XR are perfectly biphasic release (1/2 IR, 1/2 released 3.5-4 hours later). Concerta is the only triphasic. I generally do not like Vyvanse because of it's gradual release. This is also a concern with the new QHS stimulant.
Psychostimulants have more weird believes attached to them than any other class of meds
 
  • Haha
Reactions: 1 user
The overdiagnosis of ADHD is the problem. Too many crappy clinicians.

If someone from the ivory tower is reading this, you got it all wrong. ADHD should never be a diagnosis, only expressed as a symptom for something else going on with the brain.
 
  • Like
  • Dislike
Reactions: 2 users
By “long acting Ritalin” I think it’s important to differentiate between Ritalin SR and Ritalin LA. Ritalin SR is the lower efficacy wax matrix tablet. Ritalin LA is also a biphasic release bead system.
Absolutely correct, Ritalin LA is totally fine, although I would typically prefer Focalin XR in nearly every instance. It was very hard to find LA and mostly saw patients on SR.
 
I don't think a single person in this entire thread (or on this forum) was saying anything in disagreement with what you said about adult onset ADHD. The majority of the discussion has been about ensuring some stability for our patients who are suffering due to this shortage and attempts to come up with solutions. Your comment here seems a bit out of place.
A "bit out of place"? So, for all of you prescribing stimulants to adults and making money on it, considering your ethics is "in place" in my mind. If there is a shortage, maybe it is because there is an epidemic we are contributing to. Pulling out your pen and writing DA agonists for patients wanting this who happen to be sitting in front of you just get stimulants and your complacency in doing so isn't helping our credibility. I'm not a bit out of place, but right in the place more of us should be.

There are adults who benefit from stimulants and have well described childhood ADHS, but this seems to be exploding as patients become older without childhood symptoms but come to us for these drugs. I find this dubious at best and you will not be able to justify this practice behavior to most rational practitioners. It makes money and everyone is happy, but that doesn't mean we aren't the pusher man. This is out of control in my opinion.

You can call me out of place, but reflect a little bit and you might hesitate to say so out loud. The majority of adults on stimulants don't have a real indication for them. To my knowledge, there isn't a single paper on this so it is just my observation of chief complaints coming into ambulatory care with a wish for stimulants being their chief complaint is far from rare. This is frequent and clogs the systems and preclude helping people who need our help. Why wouldn't they come to us and get a 30 day supply of pills that are worth about $10 on the street?
 
  • Like
Reactions: 1 users
A "bit out of place"? So, for all of you prescribing stimulants to adults and making money on it, considering your ethics is "in place" in my mind. If there is a shortage, maybe it is because there is an epidemic we are contributing to. Pulling out your pen and writing DA agonists for patients wanting this who happen to be sitting in front of you just get stimulants and your complacency in doing so isn't helping our credibility. I'm not a bit out of place, but right in the place more of us should be.

There are adults who benefit from stimulants and have well described childhood ADHS, but this seems to be exploding as patients become older without childhood symptoms but come to us for these drugs. I find this dubious at best and you will not be able to justify this practice behavior to most rational practitioners. It makes money and everyone is happy, but that doesn't mean we aren't the pusher man. This is out of control in my opinion.

You can call me out of place, but reflect a little bit and you might hesitate to say so out loud. The majority of adults on stimulants don't have a real indication for them. To my knowledge, there isn't a single paper on this so it is just my observation of chief complaints coming into ambulatory care with a wish for stimulants being their chief complaint is far from rare. This is frequent and clogs the systems and preclude helping people who need our help. Why wouldn't they come to us and get a 30 day supply of pills that are worth about $10 on the street?
As I was reading about the regulations addressing stims, benzos and opiates...I agree it also frustrates me. As you said, there are legit individuals who need these medications. It broke my heart to read that hospice patients have a challenge getting access to their medications and amplifies my countertransference more. Although...in a situation like that, I'd hope someone can find a relatively straightforward solution where there's a different level of access to hospice patients--hospice patients are easy to identify because they get enrolled in a program and/or their insurance changes their designation of the patient. I've encountered this through medical billing.
 
  • Like
Reactions: 1 user
A "bit out of place"? So, for all of you prescribing stimulants to adults and making money on it, considering your ethics is "in place" in my mind. If there is a shortage, maybe it is because there is an epidemic we are contributing to. Pulling out your pen and writing DA agonists for patients wanting this who happen to be sitting in front of you just get stimulants and your complacency in doing so isn't helping our credibility. I'm not a bit out of place, but right in the place more of us should be.

There are adults who benefit from stimulants and have well described childhood ADHS, but this seems to be exploding as patients become older without childhood symptoms but come to us for these drugs. I find this dubious at best and you will not be able to justify this practice behavior to most rational practitioners. It makes money and everyone is happy, but that doesn't mean we aren't the pusher man. This is out of control in my opinion.

You can call me out of place, but reflect a little bit and you might hesitate to say so out loud. The majority of adults on stimulants don't have a real indication for them. To my knowledge, there isn't a single paper on this so it is just my observation of chief complaints coming into ambulatory care with a wish for stimulants being their chief complaint is far from rare. This is frequent and clogs the systems and preclude helping people who need our help. Why wouldn't they come to us and get a 30 day supply of pills that are worth about $10 on the street?

The words "adult onset ADHD" were not even mentioned in this thread until your post and nobody was talking about "pulling out your pen and writing DA agonists for patients wanting this". The whole thing was about dealing with the current med shortages for patients we do need to obtain stimulants for. There is an entire other thread about the concept of "adult onset ADHD" if you'd like to revive that.

The MSE description "tangential" comes to mind here.
 
  • Like
  • Haha
Reactions: 4 users
A "bit out of place"? So, for all of you prescribing stimulants to adults and making money on it, considering your ethics is "in place" in my mind. If there is a shortage, maybe it is because there is an epidemic we are contributing to. Pulling out your pen and writing DA agonists for patients wanting this who happen to be sitting in front of you just get stimulants and your complacency in doing so isn't helping our credibility. I'm not a bit out of place, but right in the place more of us should be.

There are adults who benefit from stimulants and have well described childhood ADHS, but this seems to be exploding as patients become older without childhood symptoms but come to us for these drugs. I find this dubious at best and you will not be able to justify this practice behavior to most rational practitioners. It makes money and everyone is happy, but that doesn't mean we aren't the pusher man. This is out of control in my opinion.

You can call me out of place, but reflect a little bit and you might hesitate to say so out loud. The majority of adults on stimulants don't have a real indication for them. To my knowledge, there isn't a single paper on this so it is just my observation of chief complaints coming into ambulatory care with a wish for stimulants being their chief complaint is far from rare. This is frequent and clogs the systems and preclude helping people who need our help. Why wouldn't they come to us and get a 30 day supply of pills that are worth about $10 on the street?
The real pros are writing Adderall 30mg IR TID so that is easily $900 at 10 bucks per pill which is honestly on the low end of an Adderall 30mg IR price around me.

Reminds me of seeing a patient in med school where the PCP was filling Oxy 20mg TID with a street value of >$2000 a month. Let's just say I was in the room with this patient who appeared to have zero opioid in her system and zero pain. It almost felt like they both acknowledged she was not actually taking the medication but that he was providing her a livelihood.
 
  • Like
  • Wow
Reactions: 3 users
The real pros are writing Adderall 30mg IR TID so that is easily $900 at 10 bucks per pill which is honestly on the low end of an Adderall 30mg IR price around me.

The street value of Adderall, I believe, is a dollar per milligram. So a typical bottle of Adderall 15 mg BID is $900, which is more than what most psychiatrists make per encounter. Given a $20 copay (or even a $400 cash visit), the profit margin highly incentivizes drug dealers/college students to get an ADHD diagnosis.
 
  • Like
  • Wow
Reactions: 1 users
The street value of Adderall, I believe, is a dollar per milligram. So a typical bottle of Adderall 15 mg BID is $900, which is more than what most psychiatrists make per encounter. Given a $20 copay (or even a $400 cash visit), the profit margin highly incentivizes drug dealers/college students to get an ADHD diagnosis.
From the stimulant UD patient's I have seen, it's around $10-20 for a 30mg tab around me. Depends on how many you are buying, if you want to see a full Rx bottle with a date that was just filled, etc.
 
Why did op get revoked on sdn?
"Abortion is a little different situation for me. That is another human life being affected and America's history of Planned Parenthood is rooted in eugenics and racism against my people. However making abortion less accessible increases crime rates in the long run and also increases the amount of left leaning citizens which also increases crime rates/civil unrest/alt left terrorism/extremism. I cannot quite figure out where I stand in this matter." -ChudsMgee
 
  • Like
Reactions: 1 user
A "bit out of place"? So, for all of you prescribing stimulants to adults and making money on it, considering your ethics is "in place" in my mind. If there is a shortage, maybe it is because there is an epidemic we are contributing to. Pulling out your pen and writing DA agonists for patients wanting this who happen to be sitting in front of you just get stimulants and your complacency in doing so isn't helping our credibility. I'm not a bit out of place, but right in the place more of us should be.

There are adults who benefit from stimulants and have well described childhood ADHS, but this seems to be exploding as patients become older without childhood symptoms but come to us for these drugs. I find this dubious at best and you will not be able to justify this practice behavior to most rational practitioners. It makes money and everyone is happy, but that doesn't mean we aren't the pusher man. This is out of control in my opinion.

You can call me out of place, but reflect a little bit and you might hesitate to say so out loud. The majority of adults on stimulants don't have a real indication for them. To my knowledge, there isn't a single paper on this so it is just my observation of chief complaints coming into ambulatory care with a wish for stimulants being their chief complaint is far from rare. This is frequent and clogs the systems and preclude helping people who need our help. Why wouldn't they come to us and get a 30 day supply of pills that are worth about $10 on the street?
So...so many things get confused, conflated, or lost in these conversations.

1. Good assessment. And no, you don't have to have a Psychologist do it and/or do hours of testing. This notion is more a reflection of the potential for frank malingering...which clinical psychiatrists seem to be absolutely terrified by despite the fact that it's the reality of seeing any human for any disorder, ever. This can be avoided by just following the DSM and other empirical paper guidance for properly assessing this disorder and using your clinical judgment based on your accumulated medical and psychological knowledge. The "I don't have time" excuse really runs thin for me many times. Make time. It's your job. Unfortunately (I guess), it is a bread-and-butter diagnosis and has been so for many, many years now. It also does not require any objective deficits on psychometric tests to meet threshold for the diagnosis. Sorry, but looking at you here too @Heist

2. The degree/reality of actual functional impairment at this point in time. Psychiatric medicine is not really meant to make things easier for you if you have a somewhat harder time modulating your attention span/distractibility and subsequent daily responsibilities. That's where patient responsibility, lifestyle modifications, and plain ole counseling come in.

3. Vetted childhood history of the disorder with ongoing functional impairment should be investigated closely to see if that's the only issue/diagnosis or main contributing factor at this time.

4. Our knowldge about placebo effects, medication expectancy, and energy or busyness in the name of productivity and/or treating a "disorder" are worthy of thinking and talking about with your patient before prescribing.

5. Have to agree with others that maybe your above points should be in the "Adult-onset ADHD thread." In which I actually dont think anyone agreed that was accurate terminology.
 
Last edited:
  • Like
Reactions: 5 users
OK everyone, you do know that "adult onset ADHD" is mostly questionable at best. You are using our relatively proud industry into the depths of embarrassment and validating the criticism of our craft. ADHD does not evaporate with patients who happen to turn 18, none the less, it doesn't become epidemic among college student who think they need stimulants' to perform at university. Adult onset "ADHD" is highly suspect until proven otherwise. The use of stimulants that are "prescribed and therefore OK" is a slippery slope. We don't want to be drug pushers. If this is part of your business plan, please review your ethics.
I won't even prescribe medication to people that come into my office that didn't have symptoms before the age of 12 but are younger than 18. ADHD is a neurodevelopmental disease. If you didn't have difficulty functioning before age 12 in more than one environment, you don't have ADHD. What is frustrating for me is that all of these adults getting meds they probably don't need has made it impossible for me to fill prescriptions for kids that absolutely cannot function to the point they often represent a risk of harm to themselves or others when they're unmedicated.

The government has really screwed up their approach to a legitimate problem, as the solution shouldn't be disrupting supply chains, it should be some way of ensuring prescriptions are appropriate to begin with. Your average person who doggedly doctor shopped for months to get stimulants is going to be more likely to pharmacy shop until they get their fix than a kid that is legitimately struggling.
 
  • Like
  • Care
Reactions: 8 users
I won't even prescribe medication to people that come into my office that didn't have symptoms before the age of 12 but are younger than 18. ADHD is a neurodevelopmental disease. If you didn't have difficulty functioning before age 12 in more than one environment, you don't have ADHD. What is frustrating for me is that all of these adults getting meds they probably don't need has made it impossible for me to fill prescriptions for kids that absolutely cannot function to the point they often represent a risk of harm to themselves or others when they're unmedicated.

The government has really screwed up their approach to a legitimate problem, as the solution shouldn't be disrupting supply chains, it should be some way of ensuring prescriptions are appropriate to begin with. Your average person who doggedly doctor shopped for months to get stimulants is going to be more likely to pharmacy shop until they get their fix than a kid that is legitimately struggling.
hahahahahahahaha /cinemasinsjeremy
 
I have a bunch of really sick 6-12 year olds who essentially have to have their parents pharmacy shop every month. We’ve returned to paper scripts because otherwise it’s a new script each time the pharmacy can’t fill it.

We’ve made many switches to easier to acquire meds, but unfortunately - these are not always equal in efficacy for these particular kids. Especially given the different time releases over the course of their school day. What a mess.

I’m the meantime, in my adult clinic, had a long term stable guy with a recent promotion come to me pan positive on ASRS demanding stims. I noted he was diaphoretic, tachycardic - he told me he was using his GFs adderall. I told him gtfo
 
  • Like
Reactions: 8 users
I have a bunch of really sick 6-12 year olds who essentially have to have their parents pharmacy shop every month. We’ve returned to paper scripts because otherwise it’s a new script each time the pharmacy can’t fill it.

We’ve made many switches to easier to acquire meds, but unfortunately - these are not always equal in efficacy for these particular kids. Especially given the different time releases over the course of their school day. What a mess.

I’m the meantime, in my adult clinic, had a long term stable guy with a recent promotion come to me pan positive on ASRS demanding stims. I noted he was diaphoretic, tachycardic - he told me he was using his GFs adderall. I told him gtfo
Completely agree, unfortunately we live in an era where said guy can hurt your income/job prospects with negative reviews. You did the right thing but I can understand why people don't.
 
  • Like
Reactions: 4 users
I have a bunch of really sick 6-12 year olds who essentially have to have their parents pharmacy shop every month. We’ve returned to paper scripts because otherwise it’s a new script each time the pharmacy can’t fill it.

We’ve made many switches to easier to acquire meds, but unfortunately - these are not always equal in efficacy for these particular kids. Especially given the different time releases over the course of their school day. What a mess.

I’m the meantime, in my adult clinic, had a long term stable guy with a recent promotion come to me pan positive on ASRS demanding stims. I noted he was diaphoretic, tachycardic - he told me he was using his GFs adderall. I told him gtfo
any recommendations for articles to cite about the ASRS and validity/specificity? It's a nightmare when clinicians use that, patients are pan positive, and they take the ASRS word for it that it must be ADHD. The specificity is terrible.
 
  • Like
Reactions: 1 user
The overdiagnosis of ADHD is the problem. Too many crappy clinicians.

If someone from the ivory tower is reading this, you got it all wrong. ADHD should never be a diagnosis, only expressed as a symptom for something else going on with the brain.
I think this can be said for a lot of our diagnoses and attentional difficulties is probably the worst culprit.
 
  • Like
Reactions: 1 users
A lot of psychiatric illnesses are overdiagnosed, even in children. You know how many not bipolar patients diagnosed at 12-13 I've seen that are doing well now that they're in therapy or being adequately treated with not bipolar medicines?

More than I have adults faking ADHD.
 
  • Like
Reactions: 4 users
The overdiagnosis of ADHD is the problem. Too many crappy clinicians.

If someone from the ivory tower is reading this, you got it all wrong. ADHD should never be a diagnosis, only expressed as a symptom for something else going on with the brain.
This is a joke right?
 
  • Like
Reactions: 1 user
Do you think this is true even for classic (childhood) diagnosis of ADHD?
Yes, because children are products of their environment. Typically poor sleep, poor discipline, poor parenting and poor academic environments are quick to label ADHD rather than modify and change the area which they live in.

If you have someone who is profound unable to "Focus and Concentrate", more than likely you have an underdiagnosed, under-realized OSA and MR. Just because we have more impulse control and conduct disorders popping up, doesn't make it ADHD.
 
  • Like
Reactions: 1 user
Top